Ligand Pharmaceuticals (LGND) Net Income - Minority (2014 - 2015)
Ligand Pharmaceuticals recorded quarterly Net Income - Minority of $2.8 million in Q1 2015, up 44.14% quarter-over-quarter from $1.9 million in Q4 2014.
Ligand Pharmaceuticals' Net Income - Minority history runs 2 years deep, the most recent figure standing at $2.8 million for Q1 2015.
- In Q1 2015, Net Income - Minority changed N/A year-over-year to $2.8 million; the TTM figure through Mar 2015 stood at $2.8 million (changed N/A YoY), while the FY2014 annual figure was $1.9 million, changed N/A from the prior year.
- Net Income - Minority came in at $2.8 million for Q1 2015 at Ligand Pharmaceuticals, up from $1.9 million in the prior quarter.
- In the past five years, Net Income - Minority ranged from a high of $2.8 million in Q1 2015 to a low of $1.1 million in Q2 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 2.75 Mn |
| Dec 31, 2014 | 1.91 Mn |
| Sep 30, 2014 | 1.59 Mn |
| Jun 30, 2014 | 1.08 Mn |